Table 3 Associations between SLE-related clinical features of 183 patients with active SLE and anti-SmD1 levels.

Clinical features	Anti-SmD1		χ ²	P	Clinical features	Anti-SmD1		χ ²	P
Clinical features	Pos	Neg	χ ²	P	Clinical features	Pos	Neg	χ ²	P
Malar rash	71	26	8.56	0.003	Seizures	12	46	13.06	0.000
Malar rash	45	41	8.56	0.003	Seizures	61	64	13.06	0.000
Discoid rash	12	8	0.11	0.739	Hematologic disorder	66	41	0.32	0.570
Discoid rash	104	59	0.11	0.739	Hematologic disorder	50	26	0.32	0.570
Rash	71	16	23.72	0.000	Hemolytic anemia	13	9	0.20	0.656
Rash	45	51	23.72	0.000	Hemolytic anemia	103	58	0.20	0.656
Photosensitivity	40	19	0.73	0.393	Leukopenia	56	35	0.27	0.605
Photosensitivity	76	48	0.73	0.393	Leukopenia	60	32	0.27	0.605
Nonscarring alopecia	53	14	11.25	0.001	Pericarditis	23	8	1.88	0.171
Nonscarring alopecia	63	53	11.25	0.001	Pericarditis	93	59	1.88	0.171
Oral ulcers	32	15	0.60	0.438	Interstitial lung disease	10	4	0.65	0.419
Oral ulcers	84	52	0.60	0.438	Interstitial lung disease	16	14	0.65	0.419
Arthritis	52	26	0.63	0.427	Pulmonary arterial hypertension	8	0		0.014
Arthritis	64	41	0.63	0.427	Pulmonary arterial hypertension	18	18		0.014
Serositis	24	11	0.50	0.479	Pulmonary infiltration	4	7	2.01	0.157
Serositis	92	56	0.50	0.479	Pulmonary infiltration	22	11	2.01	0.157
Renal disorder	46	41	7.90	0.005	Pleural effusion	4	5	0.39	0.534
Renal disorder	70	26	7.90	0.005	Pleural effusion	22	13	0.39	0.534
Proteinuria	47	39	5.34	0.021	Immunologic disorder	97	54	0.27	0.604
Proteinuria	69	28	5.34	0.021	Immunologic disorder	19	13	0.27	0.604
Hematuria	34	27	2.31	0.129	Hypocomplementemia	96	43	8.03	0.005
Hematuria	82	40	2.31	0.129	Hypocomplementemia	20	24	8.03	0.005
Neurologic disorder	25	18	0.67	0.414	Antinuclear antibody	103	61	0.23	0.630
Neurologic disorder	91	49	0.67	0.414	Antinuclear antibody	13	6	0.23	0.630

Quick links

Search